А. O. Bobkova

The use of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis during the COVID-19 coronavirus disease pandemic: data from a telephone survey of 254 patients

A. S. Potapova, V. N. Amirjanova, A. Karateev, 2022, Rheumatology Science and Practice.